● The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.21 for the 2016 fiscal year.
● The company is one of the best yield companies with high dividend expectations.
● Sales forecast by analysts have been recently revised upwards.
Weaknesses
● As estimated by analysts, this group is among those businesses with the lowest growth prospects.
● The company sustains low margins.
● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
● The group usually releases earnings worse than estimated.
● For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
● For the past seven days, analysts have been lowering their EPS expectations for the company.
● For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.